Hinge Health, Inc. (HNGE) earnings date, results and what the price requires
NYSE · SEC CIK 0001673743 · SEC filings checked Oct 22, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 4, 2026 | $212.8M | $43.7M | $0.52 | Filing |
| Mar 31, 2026 | May 5, 2026 | $182.3M | $35.1M | $0.41 | Filing |
| Dec 31, 2025 | Feb 10, 2026 | $170.7M | $32.1M | $4.04 | Filing |
| Sep 30, 2025 | Nov 4, 2025 | $154.2M | $-1.8M | $-0.02 | Filing |
| Jun 30, 2025 | Aug 5, 2025 | $139.1M | $-575.7M | $-13.10 | Filing |
| Mar 31, 2025 | — | $123.8M | $17.1M | $1.31 | — |
| Dec 31, 2024 | — | Announced; figures arrive with the 10-Q | $27.1M | — | — |
| Sep 30, 2024 | — | $100.6M | $341,000 | $0.01 | — |
What would Hinge Health, Inc. have to report for its valuation to change?
At $112.00, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 14.1% a year, to $9.57. On that path the next quarter needs diluted EPS near $-0.02, against $-0.02 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 14.1% | 14.1% |
| EPS needed in final year | $9.57 | $9.57 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. HNGE goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.